Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
1979-12-27
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0009-3378
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1-9
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:114248-Adjuvants, Immunologic,
pubmed-meshheading:114248-Animals,
pubmed-meshheading:114248-Antibody Formation,
pubmed-meshheading:114248-Guinea Pigs,
pubmed-meshheading:114248-Haptens,
pubmed-meshheading:114248-Hypersensitivity, Delayed,
pubmed-meshheading:114248-Mycobacterium tuberculosis
|
pubmed:year |
1979
|
pubmed:articleTitle |
Mode of action of a mycobacterial water-soluble adjuvant, MAF3.
|
pubmed:publicationType |
Journal Article
|